Cerlapirdine, also known as SAM-531, WAY-262,531 and PF-05212365, is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine has been in clinical development for the treatment of cognitive disorders associated with Alzheimers disease and schizophrenia. As of 2011, it is in phase II clinical trials, and has demonstrated a trend toward efficacy along with a good side effect profile and no incidence of serious adverse events. It exerts its effects by acting as a selective 5-HT6 receptor antagonist.
Molecular Weight:
445.96
CAS Number:
[925447-04-7]
Formula:
C22H24ClN3O3S
Target:
5-HT Receptor|||Others
T68330
* VAT and and shipping costs not included. Errors and price changes excepted
